The Mi-2/NuRD complex: a critical epigenetic regulator of hematopoietic development, differentiation and cancer

Epigenetics : Official Journal of the DNA Methylation Society
Julita Ramírez, James Hagman

Abstract

The Mi-2/NuRD chromatin remodeling complex links multiple transcriptional regulatory processes including histone deacetylation, histone demethylation, nucleosome mobilization and recruitment of other regulatory proteins. In some contexts, Mi-2/NuRD functions as a barrier to transcriptional activation by working in opposition to other chromatin remodelers such as SWI/SNF. Alternatively, the Mi-2beta ATPase subunit of Mi-2/NuRD can promote transcription. Together, these gatekeeper functions of Mi-2/NuRD influence cell fate decisions by modulating transcriptional activity. Recent studies have shown the importance of Mi-2/NuRD both in maintaining hematopoietic stem cell (HSC) pools and in normal lineage progression. Furthermore, components of Mi-2/NuRD complexes are modular co-repressors/co-activators comprising multiple protein subunits that have been linked directly to oncogenesis and have potential as therapeutic targets for cancer treatment. Mi-2/NuRD's essential functions in metazoan cell fates and activities underscore its importance as a focal point of epigenetic research.

Citations

Jul 28, 2012·Biochemistry·Samuel S OliverJohn M Denu
Dec 20, 2011·Nature Immunology·Kenneth J Oestreich, Amy S Weinmann
Jul 8, 2011·Nature Reviews. Cancer·Anne Y Lai, Paul A Wade
Feb 1, 2012·Molecular and Cellular Biology·Carol D Curtis, Courtney T Griffin
Feb 4, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Holly HungJohn Svaren
Nov 30, 2011·Epigenomics·Yunhe Bao
Apr 28, 2011·Gene Regulation and Systems Biology·Yue Zhang
Dec 5, 2013·ELife·Poshen B ChenThomas G Fazzio
Aug 15, 2014·Cell and Tissue Research·Irina A OkkelmanNikolay B Pestov
Nov 2, 2014·Cancer Metastasis Reviews·Yasushi Toh, Garth L Nicolson
Sep 13, 2011·Cellular and Molecular Life Sciences : CMLS·Yue Zhang, Hisashi Moriguchi
Apr 25, 2012·Cellular and Molecular Life Sciences : CMLS·Aristeidis G VaiopoulosAthanasios G Papavassiliou
May 24, 2012·Cellular and Molecular Life Sciences : CMLS·Carol D CurtisCourtney T Griffin
Apr 10, 2013·Expert Opinion on Therapeutic Targets·Brian R Rood, Dominique Leprince
Nov 23, 2012·European Journal of Immunology·Bernard CollinsJohn W Kappler
Jun 28, 2011·Biochimica Et Biophysica Acta·Fabian ErdelKarsten Rippe
Apr 15, 2011·Current Opinion in Cell Biology·Alexander R Ball, Kyoko Yokomori
Dec 18, 2010·Cytokine·Michael J Shapiro, Virginia Smith Shapiro
Jan 16, 2016·Stem Cells International·Clair E WeidgangMartin Mueller
Sep 24, 2015·Human Molecular Genetics·Louise F PorterForbes D Manson
Mar 23, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Fenyong SunQiuhui Pan
Dec 12, 2012·Cancer·Petros D Grivas, Athanasios G Papavassiliou
Jul 3, 2013·Aging Cell·Véronique De VauxChantal Wicky
May 8, 2015·Epigenomics·Teresa T Yiu, Wei Li
Oct 19, 2014·Biomolecular NMR Assignments·Louise J WalportChristina Redfield
Mar 20, 2015·BioMed Research International·Punit PrasadKarl Ekwall
Jan 10, 2012·Transcription·Magdalena Murawska, Alexander Brehm
May 9, 2012·Cell Stem Cell·Guang Hu, Paul A Wade
May 28, 2013·Chemistry & Biology·Stacey M FrummKimberly Stegmaier
Jul 19, 2016·Nucleus·Monica TyagiAshok K Patel
Aug 19, 2016·Current Opinion in Neurology·Olivier BenvenisteYves Allenbach
Mar 8, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Elizabeth A Mazzio, Karam F A Soliman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.